Daniel Brownell
Senior Director - Research & Development AOBiome Therapeutics
Dan Brownell serves as the Senior Director of Research & Development at AOBiome. With extensive experience in the R&D sector, Dan plays a pivotal role in advancing AOBiome’s innovative research initiatives. His work focuses on driving scientific discovery and developing novel solutions within the company’s specialized field. Dan’s leadership ensures that AOBiome remains at the forefront of scientific progress, translating complex research into tangible advancements. His expertise is crucial in guiding strategic development and fostering a culture of innovation.
Seminars
Tuesday 10th November 2026
Demonstrating Clinically Credible Evidence and Manufacturing Feasibility to Unlock Investment for Microbiome Therapeutics
3:30 pm
- Establishing clear pathways to regulatory approval through comparisons to existing products and demonstrated improvements in efficacy and safety to satisfy investor due diligence
- Addressing unmet therapeutic needs while showing likelihood of success to build investor confidence in achieving viable returns on capital deployed
- Communicating manufacturing scalability and cost of goods considerations for complex live bacterial production systems to address investor concerns about production feasibility
